ODI PHARMA AB (F:6OD) — Market Cap & Net Worth
Market Cap & Net Worth: ODI PHARMA AB (6OD)
ODI PHARMA AB (F:6OD) has a market capitalization of $3.31 Million (€2.83 Million) as of May 5, 2026. Listed on the F stock exchange, this Germany-based company holds position #29061 globally and #2536 in its home market, demonstrating a 8.70% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ODI PHARMA AB's stock price €0.35 by its total outstanding shares 18330419 (18.33 Million).
ODI PHARMA AB Market Cap History: 2021 to 2026
ODI PHARMA AB's market capitalization history from 2021 to 2026. Data shows change from $9.67 Million to $7.50 Million (-5.69% CAGR).
ODI PHARMA AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ODI PHARMA AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6OD by Market Capitalization
Companies near ODI PHARMA AB in the global market cap rankings as of May 5, 2026.
Key companies related to ODI PHARMA AB by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.15 |
ODI PHARMA AB Historical Marketcap From 2021 to 2026
Between 2021 and today, ODI PHARMA AB's market cap moved from $9.67 Million to $ 7.50 Million, with a yearly change of -5.69%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €7.50 Million | +7.36% |
| 2025 | €6.99 Million | +143.28% |
| 2024 | €2.87 Million | -66.67% |
| 2023 | €8.61 Million | +13.56% |
| 2022 | €7.59 Million | -21.51% |
| 2021 | €9.67 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of ODI PHARMA AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.31 Million USD |
| MoneyControl | $3.31 Million USD |
| MarketWatch | $3.31 Million USD |
| marketcap.company | $3.31 Million USD |
| Reuters | $3.31 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ODI PHARMA AB
ODI Pharma AB (publ), a pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe. It offers dried flowers; and cosmetics products under the Kandol brand. The company was founded in 2018 and is based in Stockholm, Sweden.